CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
HPV Prevention Vaccine +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06854354
NCT06854354N/ACompleted

Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers

Hospital Univeristario Benemerita Universidad Autonoma de Puebla·interventional·Posted Mar 3, 2025·Updated Mar 3, 2025

In Brief

A clinical study evaluating HPV Prevention Vaccine and Placebo for Papillomavirus Infections and Papillomavirus Vaccines. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Randomized clinical trial with two groups, with a test-retest model, with single-blind approach, using a probabilistic sampling and the population was mothers of girls aged 9 to 12 years from a public elementary school in the state of Puebla. The objective was to determine the effect of the intervention "Vaccine for HPV Prevention" aimed at the acceptance of the HPV vaccine in mothers of girls aged 9 to 12 years old in the urban area of the State of Puebla.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMexico

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 3, 2025
Enrollment StartDec 7, 2021
Primary CompletionFeb 1, 2022
Study CompletionMar 5, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.3 years ago

Interventions

HPV Prevention Vaccinebehavioral

The educational intervention was implemented through a private Facebook group, facilitating access to HPV vaccine information. A user guide was provided and profiles were verified for authenticity using a non-duplicity algorithm. Prior to access, mothers completed questionnaires to assess their knowledge, beliefs and acceptance. The intervention lasted four weeks and included four modules with videos, handouts and infographics. The first session provided information on HPV, its transmission and prevention. The second highlighted the benefits of the vaccine and debunked myths. The third showed testimonials from mothers who had their daughters vaccinated. The last session was a videoconference with group dynamics to resolve doubts. The sessions were held weekly and access and duration were monitored within the group. After finishing, the group was temporarily closed to avoid biases in the second measurement, allowing free access to the contents.

Placeboother

The CG did not have an educational intervention, nor the use of any placebo, the test instruments were applied and a month after this, they were invited to a virtual platform where they were asked to answer again the measurement instruments, once obtained the filling of the questionnaires they were invited and provided the user guide that allowed them to participate and learn about the Facebook group, as well as view the educational materials, to obtain the same benefits as the GE